These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38498459)

  • 21. Deletion of
    Potts KG; Irwin CR; Favis NA; Pink DB; Vincent KM; Lewis JD; Moore RB; Hitt MM; Evans DH
    EMBO Mol Med; 2017 May; 9(5):638-654. PubMed ID: 28289079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
    Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
    PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.
    Azar F; Deforges J; Demeusoit C; Kleinpeter P; Remy C; Silvestre N; Foloppe J; Fend L; Spring-Giusti C; Quéméneur E; Marchand JB
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39060022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
    Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA
    J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy.
    Wang S; Li Y; Xu C; Dong J; Wei J
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
    Adelfinger M; Gentschev I; Grimm de Guibert J; Weibel S; Langbein-Laugwitz J; Härtl B; Murua Escobar H; Nolte I; Chen NG; Aguilar RJ; Yu YA; Zhang Q; Frentzen A; Szalay AA
    PLoS One; 2014; 9(8):e104337. PubMed ID: 25093734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
    Draganov DD; Santidrian AF; Minev I; Nguyen D; Kilinc MO; Petrov I; Vyalkova A; Lander E; Berman M; Minev B; Szalay AA
    J Transl Med; 2019 Mar; 17(1):100. PubMed ID: 30917829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
    Schäfer S; Weibel S; Donat U; Zhang Q; Aguilar RJ; Chen NG; Szalay AA
    BMC Cancer; 2012 Aug; 12():366. PubMed ID: 22917220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
    Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.
    Guse K; Sloniecka M; Diaconu I; Ottolino-Perry K; Tang N; Ng C; Le Boeuf F; Bell JC; McCart JA; Ristimäki A; Pesonen S; Cerullo V; Hemminki A
    J Virol; 2010 Jan; 84(2):856-66. PubMed ID: 19906926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress in combination therapy of oncolytic vaccinia virus.
    Mirbahari SN; Da Silva M; Zúñiga AIM; Kooshki Zamani N; St-Laurent G; Totonchi M; Azad T
    Front Immunol; 2024; 15():1272351. PubMed ID: 38558795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of the
    Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review.
    Li M; Zhang M; Ye Q; Liu Y; Qian W
    Cancer Biol Med; 2023 Aug; 20(9):646-61. PubMed ID: 37615308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Features of the Antitumor Effect of Vaccinia Virus Lister Strain.
    Zonov E; Kochneva G; Yunusova A; Grazhdantseva A; Richter V; Ryabchikova E
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26771631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in gene therapy using oncolytic vaccinia virus as vectors.
    Yang X; Huang B; Deng L; Hu Z
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2433-2440. PubMed ID: 30293118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models.
    Cecil A; Gentschev I; Adelfinger M; Dandekar T; Szalay AA
    Bioengineered; 2019 Dec; 10(1):190-196. PubMed ID: 31142183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment.
    Nakatake M; Kuwano N; Kaitsurumaru E; Kurosaki H; Nakamura T
    Mol Ther; 2021 May; 29(5):1782-1793. PubMed ID: 33348052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.